I agree that this site is using cookies. You can find further informations here.
X
Mergui-Roelvink, M.
~ 0  results:
Search for persons X
?
1

Metabolism and disposition of the anticancer quinolone deri..:

Nijenhuis, C.M. ; Lucas, L. ; Rosing, H....
Investigational New Drugs.  35 (2017)  4 - p. 478-490 , 2017
Link: https://doi.org/10.1007/..
 
?
2

303 A phase I study of the HDM2 antagonist SAR405838 combin..:

De Weger, V. ; Varga, A. ; De Jonge, M....
European Journal of Cancer.  51 (2015)  - p. S55 , 2015
Link: https://doi.org/10.1016/..
 
?
3

Phase I and pharmacological study of pazopanib in combinati..:

Kerklaan, B Milojkovic ; Lolkema, M P J ; Devriese, L A...
British Journal of Cancer.  113 (2015)  5 - p. 706-715 , 2015
Link: https://doi.org/10.1038/..
 
?
4

Pharmacokinetics of eribulin mesylate in patients with soli..:

Devriese, L. A. ; Witteveen, P. O. ; Marchetti, S....
Cancer Chemotherapy and Pharmacology.  70 (2012)  6 - p. 823-832 , 2012
Link: https://doi.org/10.1007/..
 
?
5

Eribulin mesylate pharmacokinetics in patients with solid t..:

Devriese, L. A. ; Mergui-Roelvink, M. ; Wanders, J....
Investigational New Drugs.  31 (2012)  2 - p. 381-389 , 2012
Link: https://doi.org/10.1007/..
 
?
6

581 An Adaptive, 2-stage, Phase 1 Comparative Pharmacokinet..:

Stuurman, F.E. ; Lolkema, M.P. ; Soetekouw, P.M....
European Journal of Cancer.  48 (2012)  - p. 178 , 2012
Link: https://doi.org/10.1016/..
 
?
7

365 A Phase 1b Open-label, Dose-escalation Study of the Saf..:

Lolkema, M. ; Leong, S. ; Voest, E....
European Journal of Cancer.  48 (2012)  - p. 111-112 , 2012
Link: https://doi.org/10.1016/..
 
?
8

Phase i and pharmacological study of pazopanib in combinati..:

Kerklaan, B. Milojkovic ; Lolkema, M. P J ; Devriese, L. A...
0007-0920.  , 2015
Link: https://dspace.library.u..
 
?
9

Phase I and pharmacological study of pazopanib in combinati..:

Kerklaan, B Milojkovic ; Lolkema, M P J ; Devriese, L A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559826/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
10

A dose-escalation study of bi-daily once weekly oral doceta..:

de Weger, Vincent A. ; Stuurman, Frederik E. ; Hendrikx, Jeroen J.M.A....
European Journal of Cancer.  86 (2017)  - p. 217-225 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Pharmacokinetics and excretion of 14C-omacetaxine in patien..:

Nijenhuis, Cynthia M. ; Hellriegel, Edward ; Beijnen, Jos H....
Investigational New Drugs.  34 (2016)  5 - p. 565-574 , 2016
Link: https://doi.org/10.1007/..
 
?
12

Pharmacokinetics and excretion of 14C-lenvatinib in patient..:

Dubbelman, Anne-Charlotte ; Rosing, Hilde ; Nijenhuis, Cynthia...
Investigational New Drugs.  33 (2014)  1 - p. 233-240 , 2014
Link: https://doi.org/10.1007/..
 
?
13

Effects of low-fat and high-fat meals on steady-state pharm..:

Devriese, Lot A. ; Koch, Kevin M. ; Mergui-Roelvink, Marja...
Investigational New Drugs.  32 (2013)  3 - p. 481-488 , 2013
Link: https://doi.org/10.1007/..
 
?
14

The Effect of St John's Wort on the Pharmacokinetics of Doc..:

Goey, Andrew K. L. ; Meijerman, Irma ; Rosing, Hilde...
Clinical Pharmacokinetics.  53 (2013)  1 - p. 103-110 , 2013
Link: https://doi.org/10.1007/..
 
?
15

Erratum to: Phase I study of lonafarnib (SCH66336) in combi..:

Milojkovic Kerklaan, Bojana ; Diéras, Veronique ; Le Tourneau, Christophe...
Cancer Chemotherapy and Pharmacology.  71 (2013)  2 - p. 553-553 , 2013
Link: https://doi.org/10.1007/..
 
1-15